134 related articles for article (PubMed ID: 37356220)
1. Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications.
Zhang X; Liu SS; Ma J; Qu W
Pathol Res Pract; 2023 Aug; 248():154633. PubMed ID: 37356220
[TBL] [Abstract][Full Text] [Related]
2. Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells.
Choi BD; Jeong SJ; Wang G; Park JJ; Lim DS; Kim BH; Cho YI; Kim CS; Jeong MJ
Int J Mol Med; 2011 Oct; 28(4):527-34. PubMed ID: 21687932
[TBL] [Abstract][Full Text] [Related]
3. SLPI suppresses hepatocellular carcinoma progression via endoplasmic reticulum stress induced apoptosis.
Sun J; Li J; Wu Z; Liang Y; Duan R; Zheng M; Wang J; Kong D
Int J Biol Sci; 2022; 18(1):140-153. PubMed ID: 34975323
[TBL] [Abstract][Full Text] [Related]
4. Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis.
Nugteren S; Goos JACM; Delis-van Diemen PM; Simons-Oosterhuis Y; Lindenbergh-Kortleve DJ; van Haaften DH; Sanders J; Meijer GA; Fijneman RJA; Samsom JN
Oncoimmunology; 2020 Oct; 9(1):1832761. PubMed ID: 33101778
[TBL] [Abstract][Full Text] [Related]
5. Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer.
Zheng D; Gui B; Gray KP; Tinay I; Rafiei S; Huang Q; Sweeney CJ; Kibel AS; Jia L
Oncogene; 2016 Sep; 35(36):4807-15. PubMed ID: 26876202
[TBL] [Abstract][Full Text] [Related]
6. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
Mikami Y; Iwase T; Komiyama Y; Matsumoto N; Oki H; Komiyama K
Mol Immunol; 2015 Oct; 67(2 Pt B):568-74. PubMed ID: 26239418
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.
Hoffmann M; Quabius ES; Tribius S; Hebebrand L; Görögh T; Halec G; Kahn T; Hedderich J; Röcken C; Haag J; Waterboer T; Schmitt M; Giuliano AR; Kast WM
Oncol Rep; 2013 May; 29(5):1962-8. PubMed ID: 23467841
[TBL] [Abstract][Full Text] [Related]
8. Human uterus myoma and gene expression profiling: A novel in vitro model for studying secretory leukocyte protease inhibitor-mediated tumor invasion.
Mikami Y; Fukushima A; Komiyama Y; Iwase T; Tsuda H; Higuchi Y; Hayakawa S; Kuyama K; Komiyama K
Cancer Lett; 2016 Aug; 379(1):84-93. PubMed ID: 27238568
[TBL] [Abstract][Full Text] [Related]
9. Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.
Svensson D; Aidoukovitch A; Anders E; Jönsson D; Nebel D; Nilsson BO
Inflamm Res; 2017 Sep; 66(9):823-831. PubMed ID: 28597116
[TBL] [Abstract][Full Text] [Related]
10. Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells.
Hoskins E; Rodriguez-Canales J; Hewitt SM; Elmasri W; Han J; Han S; Davidson B; Kohn EC
Gynecol Oncol; 2011 Sep; 122(3):656-62. PubMed ID: 21676452
[TBL] [Abstract][Full Text] [Related]
11. Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma.
Wen J; Nikitakis NG; Chaisuparat R; Greenwell-Wild T; Gliozzi M; Jin W; Adli A; Moutsopoulos N; Wu T; Warburton G; Wahl SM
Am J Pathol; 2011 Jun; 178(6):2866-78. PubMed ID: 21641406
[TBL] [Abstract][Full Text] [Related]
12. Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer.
Nugteren S; Samsom JN
Cytokine Growth Factor Rev; 2021 Jun; 59():22-35. PubMed ID: 33602652
[TBL] [Abstract][Full Text] [Related]
13. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
[TBL] [Abstract][Full Text] [Related]
14. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation.
Klimenkova O; Ellerbeck W; Klimiankou M; Ünalan M; Kandabarau S; Gigina A; Hussein K; Zeidler C; Welte K; Skokowa J
Blood; 2014 Feb; 123(8):1239-49. PubMed ID: 24352879
[TBL] [Abstract][Full Text] [Related]
15. High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence.
Nugteren S; den Uil SH; Delis-van Diemen PM; Simons-Oosterhuis Y; Lindenbergh-Kortleve DJ; van Haaften DH; Stockmann HBAC; Sanders J; Meijer GA; Fijneman RJA; Samsom JN
Sci Rep; 2022 Jul; 12(1):12174. PubMed ID: 35842496
[TBL] [Abstract][Full Text] [Related]
16. Secretory leukocyte peptidase inhibitor and lung cancer.
Nukiwa T; Suzuki T; Fukuhara T; Kikuchi T
Cancer Sci; 2008 May; 99(5):849-55. PubMed ID: 18380788
[TBL] [Abstract][Full Text] [Related]
17. Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells.
Rosso M; Lapyckyj L; Amiano N; Besso MJ; Sánchez M; Chuluyan E; Vazquez-Levin MH
Biol Cell; 2014 Sep; 106(9):308-22. PubMed ID: 25039920
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
[TBL] [Abstract][Full Text] [Related]
19. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F
Gene; 2019 Dec; 720():144088. PubMed ID: 31476404
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of secretory leukocyte protease inhibitor (SLPI) promotes the PUMA-mediated apoptosis and chemosensitivity to cisplatin in colorectal cancer cells.
Wei Z; Liu G; Jia R; Zhang W; Li L; Zhang Y; Wang Z; Bai X
Discov Oncol; 2023 Jan; 14(1):1. PubMed ID: 36595102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]